Cargando…
Mutant B2M‐HLA‐E and B2M‐HLA‐G fusion proteins protects universal chimeric antigen receptor‐modified T cells from allogeneic NK cell‐mediated lysis
Recent studies have indicated the antitumor activity and reduced allogeneic response of universal chimeric antigen receptor‐modified T (UCAR T) cells lacking endogenous T cell receptors and beta‐2 microglobulin (B2M) generated using gene‐editing technologies. However, these cells are vulnerable to l...
Autores principales: | Guo, Yelei, Xu, Beilei, Wu, Zhiqiang, Bo, Jian, Tong, Chuan, Chen, Deyun, Wang, Jin, Wang, Haoyi, Wang, Yao, Han, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292285/ https://www.ncbi.nlm.nih.gov/pubmed/34323289 http://dx.doi.org/10.1002/eji.202049107 |
Ejemplares similares
-
Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression
por: McCarthy, Michael T., et al.
Publicado: (2019) -
Chimeric antigen receptor‐modified human regulatory T cells that constitutively express IL‐10 maintain their phenotype and are potently suppressive
por: Mohseni, Yasmin R., et al.
Publicado: (2021) -
Icaritin inhibits PD‐L1 expression by Targeting Protein IκB Kinase α
por: Mo, Dongliang, et al.
Publicado: (2021) -
HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors
por: Sottile, Rosa, et al.
Publicado: (2015) -
Termination of CD40L co‐stimulation promotes human B cell differentiation into antibody‐secreting cells
por: Marsman, Casper, et al.
Publicado: (2022)